2-240029785-T-C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001005853.1(OR6B2):c.645A>G(p.Ile215Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000221 in 1,609,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005853.1 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152054Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000842 AC: 21AN: 249418 AF XY: 0.0000739 show subpopulations
GnomAD4 exome AF: 0.000228 AC: 332AN: 1456846Hom.: 0 Cov.: 29 AF XY: 0.000239 AC XY: 173AN XY: 725066 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.000151 AC: 23AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74396 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.645A>G (p.I215M) alteration is located in exon 1 (coding exon 1) of the OR6B2 gene. This alteration results from a A to G substitution at nucleotide position 645, causing the isoleucine (I) at amino acid position 215 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at